|
Warum geht es so abwärts mit Geron? Vielleicht liegt hier die Antwort verborgen Reuters EntreMed Up on Experimental Cancer Drug Wednesday April 23, 11:37 am ET NEW YORK (Reuters) - Shares of EntreMed Inc. (NasdaqNM:ENMD - News) soared for the second straight day on Wednesday after the biotechnology company said its experimental cancer drug blocks a protein linked to several types of cancer. ADVERTISEMENT The shares were up as much as 52 percent after more than doubling on Tuesday. On Tuesday, EntreMed said tests of its Panzem drug in animals confirmed that its anti-cancer activity stems, in part, from its ability to inhibit production of a protein called hypoxia inducible factor 1, or HIF. The human body produces too much HIF in more than 70 percent of cancers, including breast cancer, prostate cancer, brain cancer, lung cancer and head and neck cancers, according to the company. EntreMed said it would continue developing Panzem for cancer and would consider testing it against other disorders linked with HIF, including arthritis and heart disease. EntreMed shares were up $1.22, or 44 percent, at $3.97 in late-morning trading on the Nasdaq stock market after soaring as high as $4.19 earlier in the session. Die Charttechnik lässt auch ungemach befürchten da sich eine SKS-Formation enrwickelt hat.Aber ich bin nur Laie in der Interpretation von Charts gruss meislo |
|
| aus der Diskussion: | Geron mit Hammernews!! |
| Autor (Datum des Eintrages): | meislo (23.04.03 17:51:10) |
| Beitrag: | 100 von 3,090 (ID:9244885) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |